<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: AIS News</title><copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=ais</link><description>Latest Financial News for ANTARES PHARMA INC</description><language>en-us</language><lastBuildDate>Tue, 17 Nov 2009 14:04:26 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>ANTARES PHARMA, INC. Financials (EDGAR Online Financials)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=ais</link><description></description><guid isPermaLink="false">yahoo_finance/2921436177</guid><pubDate>Tue, 17 Nov 2009 14:04:26 Etc/GMT</pubDate></item><item><title>Coverage initiated on Antares Pharma by Merriman (Briefing.com)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/ud?s=AIS</link><description></description><guid isPermaLink="false">yahoo_finance/603784366</guid><pubDate>Tue, 17 Nov 2009 05:28:17 Etc/GMT</pubDate></item><item><title>ANTARES PHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091112/ais8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/4256575101</guid><pubDate>Thu, 12 Nov 2009 14:35:12 Etc/GMT</pubDate></item><item><title>Antares Pharma Enters into License and Asset Purchase Agreements with Ferring (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091111/20091111005052.html?.v=1</link><description>EWING, N.J.----Antares Pharma, Inc. today announced the simultaneous signing of a license and an asset purchase agreement with Ferring International Center S.A. Under the terms of the exclusive license agreement Ferring obtained rights to certain intellectual property relating to Antares’ proprietary transdermal gel delivery technology.</description><guid isPermaLink="false">yahoo_finance/1073433317</guid><pubDate>Wed, 11 Nov 2009 13:00:00 Etc/GMT</pubDate></item><item><title>Antares Pharma, Inc. Earnings Call scheduled for 4:30 pm ET today (CCBN)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/cc/6/109096.html</link><description></description><guid isPermaLink="false">yahoo_finance/3294001440</guid><pubDate>Mon, 9 Nov 2009 21:30:00 Etc/GMT</pubDate></item><item><title>ANTARES PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091109/ais8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/2071447625</guid><pubDate>Mon, 9 Nov 2009 21:13:59 Etc/GMT</pubDate></item><item><title>Antares Pharma Reports Third Quarter 2009 Financial and Operating Results (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091109/20091109006425.html?.v=1</link><description>EWING, N.J.----Antares Pharma, Inc. today reported financial and operating results for the third quarter ended September 30, 2009.</description><guid isPermaLink="false">yahoo_finance/2850999624</guid><pubDate>Mon, 9 Nov 2009 21:05:00 Etc/GMT</pubDate></item><item><title>Q3 2009 Antares Pharma, Inc. Earnings Release - After Market Close (CCBN)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/research/earncal/20091109.html?t=ais</link><description></description><guid isPermaLink="false">yahoo_finance/3599479769</guid><pubDate>Mon, 9 Nov 2009 12:07:23 Etc/GMT</pubDate></item><item><title>Antares Pharma to Present at the Merriman Investor Summit 2009 (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091103/20091103005290.html?.v=1</link><description>EWING, N.J.----Antares Pharma, Inc. today announced that Dr. Paul K. Wotton, Ph.D., President and Chief Executive Officer, will present at the Merriman Investor Summit 2009 on Tuesday, November 10, 2009 at 11:00 am ET .</description><guid isPermaLink="false">yahoo_finance/1082679967</guid><pubDate>Tue, 3 Nov 2009 21:05:00 Etc/GMT</pubDate></item><item><title>Antares Pharma to Host Third Quarter 2009 Earnings Call (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091102/20091102006478.html?.v=1</link><description>EWING, N.J.----Antares Pharma, Inc. today announced that it will release its third quarter 2009 financial results after the market closes on Monday, November 9, 2009, and host a conference call shortly thereafter at 4:30 PM to discuss the results.</description><guid isPermaLink="false">yahoo_finance/1696577804</guid><pubDate>Mon, 2 Nov 2009 21:49:00 Etc/GMT</pubDate></item><item><title>Antares Pharma to Present at the 20th Annual Oppenheimer Healthcare Conference (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091027/20091027006704.html?.v=1</link><description>EWING, N.J.----Antares Pharma, Inc. today announced that Dr. Paul K Wotton, Ph.D., President and Chief Executive Officer, will present at the 20th Annual Oppenheimer Healthcare Conference on Tuesday, November 3, 2009 at 4:30 pm ET .</description><guid isPermaLink="false">yahoo_finance/1899555258</guid><pubDate>Tue, 27 Oct 2009 21:05:00 Etc/GMT</pubDate></item><item><title>New Injectable Technology Platform For Growth Hormone Could Lead To Other Near Term Product Introductions: Catalyst For Potential Acquisition According To Ladenburg Thalmann Industry Expert (Wall Street Transcript)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/twst/091020/biotechnew13.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3502795896</guid><pubDate>Tue, 20 Oct 2009 11:53:00 Etc/GMT</pubDate></item><item><title>Midday Movers: Pump Up the Volume (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12qssdp49/*http%3A//www.thestreet.com/_yahoo/story/10612836/1/midday-movers-pump-up-the-volume.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/1651580723</guid><pubDate>Fri, 16 Oct 2009 18:45:32 Etc/GMT</pubDate></item><item><title>ANTARES PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibit (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090918/ais8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/3205514684</guid><pubDate>Fri, 18 Sep 2009 14:33:28 Etc/GMT</pubDate></item><item><title>ANTARES PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090814/ais8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/2126471381</guid><pubDate>Fri, 14 Aug 2009 15:38:23 Etc/GMT</pubDate></item><item><title>ANTARES PHARMA, INC. Files SEC form 10-Q, Quarterly Report (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090813/ais10-q.html</link><description></description><guid isPermaLink="false">yahoo_finance/1104334495</guid><pubDate>Thu, 13 Aug 2009 13:02:12 Etc/GMT</pubDate></item><item><title>Antares Pharma, Inc. Earnings Call scheduled for 8:30 am ET today (CCBN)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/cc/6/106846.html</link><description></description><guid isPermaLink="false">yahoo_finance/3472610582</guid><pubDate>Thu, 13 Aug 2009 12:30:00 Etc/GMT</pubDate></item><item><title>ANTARES PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibit (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090724/ais8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/2747581551</guid><pubDate>Fri, 24 Jul 2009 13:25:40 Etc/GMT</pubDate></item><item><title>ANTARES PHARMA, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standa (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090605/ais8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/2392209617</guid><pubDate>Fri, 5 Jun 2009 20:19:17 Etc/GMT</pubDate></item><item><title>ANTARES PHARMA, INC. Files SEC form 10-Q, Quarterly Report (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090513/ais10-q.html</link><description></description><guid isPermaLink="false">yahoo_finance/2052089596</guid><pubDate>Wed, 13 May 2009 20:45:01 Etc/GMT</pubDate></item></channel></rss><!-- c6.finance.sp2.yahoo.com compressed/chunked Mon Dec 28 06:15:31 PST 2009 -->
